[email protected]
Research paper published by the Actinogen team diving into the current literature on 11BHSD1 inhibition. They describe some potential future indications for Xanamem but nothing conclusive - the science is still quite unclear on this one unfortunately.
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.003(13.0%) |
Mkt cap ! $82.60M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.6¢ | 2.4¢ | $101.9K | 4.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1061873 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 315142 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
| ACW (ASX) Chart |